4//SEC Filing
McMahon Daniel J 4
Accession 0001213900-18-007273
CIK 0001611277other
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 5:56 PM ET
Size
15.8 KB
Accession
0001213900-18-007273
Insider Transaction Report
Form 4
Helix TCS, Inc.HLIX
McMahon Daniel J
Director
Transactions
- Award
Stock Option (Right to Buy)
2018-06-01+68,339→ 68,339 totalExercise: $0.79Exp: 2026-07-31→ Common Stock (68,339 underlying) - Award
Common Stock
2018-06-01+26,954→ 26,954 total - Award
Stock Option (Right to Buy)
2018-06-01+26,954→ 26,954 totalExercise: $0.11Exp: 2025-02-28→ Common Stock (26,954 underlying) - Award
Stock Option (Right to Buy)
2018-06-01+150,072→ 150,072 totalExercise: $1.66Exp: 2028-05-29→ Common Stock (150,072 underlying) - Award
Stock Option (Right to Buy)
2018-06-01+11,715→ 11,715 totalExercise: $1.66Exp: 2028-05-29→ Common Stock (11,715 underlying)
Footnotes (5)
- [F1]Received in exchange for 2,761 shares of Bio-Tech Software, Inc. (?BioTrackTHC?) stock in connection with its merger into Helix Acquisition Sub, Inc., a wholly-owned subsidiary of the Issuer (the ?Merger?). Of the 26,954 shares issued to the Reporting Person in connection with the Merger, 1,453 shares are currently being held in escrow and are subject to forfeiture during the eighteen-month period following the Merger to satisfy indemnification obligations of the Issuer, if any.
- [F2]Received in the Merger in exchange for an employee stock option to acquire 2,761 shares of BioTrackTHC common stock for $1.00 per share. The stock option is fully vested.
- [F3]Received in the Merger in exchange for an employee stock option to acquire 7,000 shares of BioTrackTHC common stock for $7.67 per share. The stock option vests 25% on each annual anniversary, beginning on February 7, 2017, subject to the Reporting Person?s continued employment with BioTrackTHC.
- [F4]Received in the Merger in exchange for an employee stock option to acquire 15,372 shares of BioTrackTHC common stock for $16.11 per share. The stock option vested 25% on May 30, 2018 and the remaining 75% of the shares subject to the stock option vest 25% on the annual anniversary, beginning on February 7, 2019, subject to the Reporting Person?s continued employment with BioTrackTHC.
- [F5]Received in the Merger in exchange for an employee stock option to acquire 1,200 shares of BioTrackTHC common stock for $16.11 per share. The stock option vests 25% on each annual anniversary, beginning on February 7, 2019, subject to the Reporting Person?s continued employment with BioTrackTHC.
Documents
Issuer
Helix TCS, Inc.
CIK 0001611277
Entity typeother
Related Parties
1- filerCIK 0001742472
Filing Metadata
- Form type
- 4
- Filed
- Jun 4, 8:00 PM ET
- Accepted
- Jun 5, 5:56 PM ET
- Size
- 15.8 KB